{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:20:34Z","timestamp":1779916834027,"version":"3.53.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.medcli.2017.09.013","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T17:31:38Z","timestamp":1510680698000},"page":"434-442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Miocardiopat\u00eda hipertr\u00f3fica"],"prefix":"10.1016","volume":"150","author":[{"given":"Juan Jos\u00e9","family":"Santos Mateo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sabater Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ram\u00f3n","family":"Gimeno Blanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2017.09.013_bib0280","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: A position statement from the European Society of Cardiology","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2017.09.013_bib0285","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2017.09.013_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/hrt.20.1.1","article-title":"Asymmetrical hypertrophy of the heart in young adults","volume":"20","author":"Teare","year":"1958","journal-title":"Br Heart J."},{"key":"10.1016\/j.medcli.2017.09.013_bib0295","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation","volume":"62","author":"Geisterfer-Lowrance","year":"1990","journal-title":"Cell."},{"key":"10.1016\/j.medcli.2017.09.013_bib0300","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","article-title":"Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy","volume":"332","author":"Watkins","year":"1995","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2017.09.013_bib0305","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/hrt.82.5.621","article-title":"A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy","volume":"82","author":"Varnava","year":"1999","journal-title":"Heart."},{"key":"10.1016\/j.medcli.2017.09.013_bib0310","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy. Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.medcli.2017.09.013_bib0315","first-page":"1","article-title":"Genetics of hypertrophic cardiomyopathy: A review of current state","author":"Sabater-Molina","year":"2017","journal-title":"Clin Genet."},{"key":"10.1016\/j.medcli.2017.09.013_bib0320","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/heartjnl-2014-306387","article-title":"Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy","volume":"101","author":"Lopes","year":"2015","journal-title":"Heart."},{"key":"10.1016\/j.medcli.2017.09.013_bib0325","first-page":"105","article-title":"A novel founder mutation in MYBPC3: Phenotypic comparison with the most prevalent MYBPC3 mutation in Spain","volume":"70","author":"Sabater","year":"2017","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0330","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2796.2005.01539.x","article-title":"Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects","volume":"258","author":"Konno","year":"2005","journal-title":"J Intern Med."},{"key":"10.1016\/j.medcli.2017.09.013_bib0335","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1136\/hrt.2010.200402","article-title":"Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3","volume":"96","author":"Oliva-Sandoval","year":"2010","journal-title":"Heart."},{"key":"10.1016\/j.medcli.2017.09.013_bib0340","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","article-title":"A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations","volume":"9","author":"Lopes","year":"2013","journal-title":"Heart."},{"key":"10.1016\/j.medcli.2017.09.013_bib0345","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"10.1016\/j.medcli.2017.09.013_bib0350","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCGENETICS.111.960831","article-title":"Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: Disease expression in relation to age, gender, and long term outcome","volume":"5","author":"Page","year":"2012","journal-title":"Circ Cardiovasc Genet."},{"key":"10.1016\/j.medcli.2017.09.013_bib0355","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ejhg.2012.48","article-title":"The role of renin-angiotensin-aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy","volume":"20","author":"Kolder","year":"2012","journal-title":"Eur J Hum Genet."},{"key":"10.1016\/j.medcli.2017.09.013_bib0360","article-title":"Factores que influyen en la expresi\u00f3n fenot\u00edpica de la miocardiopat\u00eda hipertr\u00f3fica en portadores gen\u00e9ticos","author":"P\u00e9rez-S\u00e1nchez","year":"2017","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0365","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/heart.84.5.476","article-title":"Hypertrophic cardiomyopathy: The interrelation of disarray, fibrosis, and small vessel disease","volume":"84","author":"Varnava","year":"2000","journal-title":"Heart."},{"key":"10.1016\/j.medcli.2017.09.013_bib0370","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjcard.2009.03.055","article-title":"Penetrance and risk profile in inherited cardiac diseases studied in a dedicated screening clinic","volume":"104","author":"Gimeno","year":"2009","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0375","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/eurheartj\/ehq271","article-title":"Genetic counselling and testing in cardiomyopathies: A position statement of the European Society of Cardiology","volume":"31","author":"Charron","year":"2010","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2017.09.013_bib0380","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/hrt.77.2.130","article-title":"Experience from clinical genetics in hypertrophic cardiomyopathy: Proposal for new diagnostic criteria in adult members of affected families","volume":"77","author":"McKenna","year":"1997","journal-title":"Heart."},{"key":"10.1016\/j.medcli.2017.09.013_bib0385","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.recesp.2015.11.031","article-title":"Plan of action for inherited cardiovascular diseases: Synthesis of recommendations and action algorithms","volume":"69","author":"Barriales-Villa","year":"2016","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0390","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2017.09.013_bib0395","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/hrt.2005.068577","article-title":"Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy","volume":"92","author":"Elliott","year":"2006","journal-title":"Heart."},{"key":"10.1016\/j.medcli.2017.09.013_bib0400","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(04)16358-7","article-title":"Hypertrophic cardiomyopathy","volume":"363","author":"Elliott","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2017.09.013_bib0405","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrcardio.2016.140","article-title":"Update on hypertrophic cardiomyopathy and a guide to the guidelines","volume":"13","author":"Sen-Chowdhry","year":"2016","journal-title":"Nat Rev Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0410","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation."},{"key":"10.1016\/j.medcli.2017.09.013_bib0415","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/hrt.2003.031161","article-title":"Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy","volume":"91","author":"Thaman","year":"2005","journal-title":"Heart."},{"key":"10.1016\/j.medcli.2017.09.013_bib0420","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","article-title":"2011 ACCF\/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"58","author":"Gersh","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0425","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4065\/81.4.459","article-title":"Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: Septal morphological features predict the presence of myofilament mutations","volume":"81","author":"Binder","year":"2006","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.medcli.2017.09.013_bib0430","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijcard.2016.06.044","article-title":"Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry","volume":"219","author":"Ciampi","year":"2016","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0435","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ehjci\/jeu291","article-title":"Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: An expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association","volume":"16","author":"Cardim","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1016\/j.medcli.2017.09.013_bib0440","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/10976640600605002","article-title":"The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease","volume":"8","author":"Moon","year":"2006","journal-title":"J Cardiovasc Magn Reson."},{"key":"10.1016\/j.medcli.2017.09.013_bib0445","doi-asserted-by":"crossref","first-page":"e003285","DOI":"10.1161\/CIRCIMAGING.115.003285","article-title":"T1 Mapping in discrimination of hypertrophic phenotypes: Hypertensive heart disease and hypertrophic cardiomyopathy: Findings from the International T1 Multicenter Cardiovascular Magnetic Resonance Study","volume":"8","author":"Hinojar","year":"2015","journal-title":"Circ Cardiovasc Imaging."},{"key":"10.1016\/j.medcli.2017.09.013_bib0450","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/eurheartj\/ehp327","article-title":"Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy","volume":"30","author":"Gimeno","year":"2009","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2017.09.013_bib0455","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: Bridging the gap between clinical phenotypes and final diagnosis","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2017.09.013_bib0460","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","article-title":"Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy","volume":"50","author":"Monserrat","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0465","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2017.09.013_bib0470","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2003.03.002","article-title":"Does sports activity enhance the risk of sudden death in adolescents and young adults?","volume":"42","author":"Corrado","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0475","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0480","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0485","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/heartjnl-2012-303339","article-title":"Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: Low incidence of sudden cardiac death and reduced risk profile","volume":"99","author":"Jensen","year":"2013","journal-title":"Heart."},{"key":"10.1016\/j.medcli.2017.09.013_bib0490","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2009.09.047","article-title":"Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy","volume":"55","author":"Agarwal","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.medcli.2017.09.013_bib0495","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/01.CIR.99.22.2927","article-title":"Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)","volume":"99","author":"Maron","year":"1999","journal-title":"Circulation."},{"key":"10.1016\/j.medcli.2017.09.013_bib0500","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2017.09.013_bib0505","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2017.09.013_bib0510","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ejhf.316","article-title":"Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA)","volume":"17","author":"Guttmann","year":"2015","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.medcli.2017.09.013_bib0515","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2017.09.013_bib0520","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jchf.2014.08.003","article-title":"Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: A pilot randomized trial to modify disease expression","volume":"3","author":"Ho","year":"2015","journal-title":"J Am Col Cardio Heart Fail."},{"key":"10.1016\/j.medcli.2017.09.013_bib0525","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ejhf.541","article-title":"Pharmacological treatment of hypertrophic cardiomyopathy: Current practice and novel perspectives","volume":"18","author":"Ammirati","year":"2016","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.medcli.2017.09.013_bib0530","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science."},{"key":"10.1016\/j.medcli.2017.09.013_bib0535","doi-asserted-by":"crossref","first-page":"e003565","DOI":"10.1161\/CIRCHEARTFAILURE.116.003565","article-title":"Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy","volume":"10","author":"Coppini","year":"2017","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.medcli.2017.09.013_bib0540","first-page":"245","article-title":"Splicing modulation therapy in the treatment of genetic diseases","volume":"7","author":"Arechavala-Gomeza","year":"2014","journal-title":"Appl Clin Genet."},{"key":"10.1016\/j.medcli.2017.09.013_bib0545","doi-asserted-by":"crossref","first-page":"e2393","DOI":"10.1038\/cddis.2016.304","article-title":"Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia","volume":"7","author":"Lodola","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.medcli.2017.09.013_bib0550","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1038\/ncomms7955","article-title":"Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy","volume":"6","author":"Karakikes","year":"2015","journal-title":"Nat Commun."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317307145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317307145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T22:31:54Z","timestamp":1535236314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775317307145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0025775317307145"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.09.013","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Miocardiopat\u00eda hipertr\u00f3fica","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}